IGF-1 peptide is a synthetic version of the human insulin-like growth factor 1 (IGF-1) hormone. It is used for a variety of purposes, including:
- Treating growth hormone deficiency: IGF-1 peptide can be used to treat children and adolescents with growth hormone deficiency.
- Treating muscle wasting: IGF-1 peptide can be used to treat muscle wasting in people with conditions such as AIDS, cancer, and chronic kidney disease.
- Treating osteoporosis: IGF-1 peptide can be used to treat osteoporosis, a condition that causes bones to become weak and brittle.
- Treating diabetes: IGF-1 peptide is being investigated as a potential treatment for diabetes.
- Treating heart disease: IGF-1 peptide is being investigated as a potential treatment for heart disease and stroke.
- Treating cancer: IGF-1 peptide is being investigated as a potential treatment for cancer.
- Treating Alzheimer’s disease: IGF-1 peptide is being investigated as a potential treatment for Alzheimer’s disease.
IGF-1 peptide is administered by injection. It is important to note that IGF-1 peptide is not approved by the US Food and Drug Administration (FDA) for any of these uses. It is considered an investigational drug and is only available through clinical trials.
Potential benefits of IGF-1 peptide
IGF-1 peptide has a number of potential benefits, including:
- Promoting growth and development in children and adolescents
- Maintaining muscle mass and bone density in adults
- Regulating metabolism and glucose levels
- Protecting against age-related diseases, such as heart disease, stroke, and cancer
Potential risks of IGF-1 peptide
IGF-1 peptide also has some potential risks, including:
- Increased risk of cancer
- Hypoglycemia (low blood sugar)
- Fluid retention
- Muscle cramps
- Joint pain
- Headache
- Nausea and vomiting
Is IGF-1 peptide safe?
The safety of IGF-1 peptide is still being investigated. More research is needed to determine the long-term safety of IGF-1 peptide use.
Who should not use IGF-1 peptide?
IGF-1 peptide should not be used by people who:
- Have cancer
- Are pregnant or breastfeeding
- Have diabetes
- Have heart disease
- Have kidney disease
- Are taking certain medications, such as insulin or corticosteroids
IGF-1 peptide is a synthetic version of the human insulin-like growth factor 1 (IGF-1) hormone. It is used for a variety of purposes, including treating growth hormone deficiency, muscle wasting, osteoporosis, and other conditions. IGF-1 peptide is administered by injection and is not approved by the US Food and Drug Administration (FDA) for any of these uses. It is considered an investigational drug and is only available through clinical trials.
IGF-1 peptide has a number of potential benefits, but it also has some potential risks, including an increased risk of cancer. More research is needed to determine the long-term safety of IGF-1 peptide use.
IGF-1 peptide should not be used by people who have cancer, are pregnant or breastfeeding, have diabetes, have heart disease, have kidney disease, or are taking certain medications.
